Psyence Biomedical logo

Psyence Biomedical Share Price (NASDAQ: PBM)

$2.76

-0.21

(-7.07%)

Last updated on

Check the interactive Psyence Biomedical Stock chart to analyse performance

Psyence Biomedical stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.67
    Today's High:$2.91

    Day's Volatility :8.25%

  • 52 Weeks Low:$2.36
    52 Weeks High:$258.23

    52 Weeks Volatility :99.09%

Psyence Biomedical Stock Returns

PeriodPsyence Biomedical LtdIndex (Russel 2000)
3 Months
-39.87%
0.0%
6 Months
-66.01%
0.0%
1 Year
-98.7%
0.0%
3 Years
-99.8%
-4.7%

Psyence Biomedical Ltd Key Stats

Check Psyence Biomedical key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.97
Open
$2.91
Today's High
$2.91
Today's Low
$2.67
Market Capitalization
$2.1M
Today's Volume
$118.5K
52 Week High
$258.225
52 Week Low
$2.36
Revenue TTM
$0.0
EBITDA
$-3.7M
Earnings Per Share (EPS)
$41.76
PE Ratio
0.07
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Psyence Biomedical Stock including INR - Dollar returns

The Psyence Biomedical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Psyence Biomedical investment value today

Current value as on today

₹6,411

Returns

₹93,589

(-93.59%)

Returns from Psyence Biomedical Stock

₹98,873 (-98.87%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Psyence Biomedical Stock

3228.57%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Psyence Biomedical Shares from India has grown by 3228.57% over the past 30 days, indicating increased transactional activity.

764%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Psyence Biomedical Stock from India on INDmoney has increased by 764% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Psyence Biomedical Stock

Rating
Trend

Psyence Biomedical Stock Insights

  • Price Movement

    In the last 7 days, PBM stock has moved down by -13.9%
  • PBM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 168.8%

Psyence Biomedical Technicals Summary

Sell

Neutral

Buy

Psyence Biomedical is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Psyence Biomedical Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Psyence Biomedical Ltd logo
18.22%
-66.01%
-98.7%
-99.8%
-99.8%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Psyence Biomedical Ltd

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.
Organization
Psyence Biomedical
Employees
12
CEO
Dr. Neil Maresky M.D.
Industry
Miscellaneous

Key Management of Psyence Biomedical Ltd

NameTitle
Mr. Jody Aufrichtig
Co-Founder, Executive Chairman & Strategic Business Development Officer
Dr. Neil Maresky M.D.
CEO & Director
Mr. Warwick Ron Corden-Lloyd
Chief Financial Officer
Ms. Taryn Vos
General Counsel

Important FAQs about investing in PBM Stock from India :

What is Psyence Biomedical share price today?

Psyence Biomedical share price today is $2.76 as on at the close of the market. Psyence Biomedical share today touched a day high of $2.91 and a low of $2.67.

What is the 52 week high and 52 week low for Psyence Biomedical share?

Psyence Biomedical share touched a 52 week high of $258.23 and a 52 week low of $2.36. Psyence Biomedical stock price today i.e. is closed at $2.76, lower by 98.93% versus the 52 week high.

How to invest in Psyence Biomedical Stock (PBM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Psyence Biomedical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Psyence Biomedical Shares that will get you 0.5435 shares as per Psyence Biomedical share price of $2.76 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Psyence Biomedical Stock (PBM) from India?

Indian investors can start investing in Psyence Biomedical (PBM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Psyence Biomedical stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Psyence Biomedical share’s latest price of $2.76 as on August 30, 2025 at 1:29 am IST, you will get 3.6232 shares of Psyence Biomedical. Learn more about fractional shares .

What are the returns that Psyence Biomedical has given to Indian investors in the last 5 years?

Psyence Biomedical stock has given -99.8% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?